Effect of statins on SARS-CoV-2 infection

The retrospective analysis of clinical data of patients suffering from COVID-19 has indicated that statin therapy, used to lower plasma cholesterol levels, is associated with a better clinical outcome. We therefore investigated the effect of statins on SARS-CoV-2 infection and found that selective statins reduced SARS-CoV-2 cell entry and inhibited high and low pathogenic coronavirus infection in human cells. A retrospective study on hospitalized patients with COVID-19 implies that reduced high density lipoprotein levels, which are typically counteracted by statin therapy, are associated with aggravated disease outcome. These results suggest that statin therapy poses no additional risk to individuals exposed to SARS-CoV-2 and that some statins may have a mild beneficial effect on COVID-19 outcome.

[1]  M. Müller,et al.  Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2 , 2020, Nature.

[2]  Qingbo Xu,et al.  In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19 , 2020, Cell Metabolism.

[3]  Amit N. Patel,et al.  Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 , 2020, The New England journal of medicine.

[4]  Wenjuan Zeng,et al.  Hypolipidemia is associated with the severity of COVID-19 , 2020, Journal of Clinical Lipidology.

[5]  M. Hoffmann,et al.  A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells , 2020, Molecular Cell.

[6]  M. Banach,et al.  Statins and the COVID-19 main protease: in silico evidence on direct interaction , 2020, Archives of medical science : AMS.

[7]  N. G. Davies,et al.  Age-dependent effects in the transmission and control of COVID-19 epidemics , 2020, Nature Medicine.

[8]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[9]  Gengfu Xiao,et al.  Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro , 2020, Cell Research.

[10]  Victor M Corman,et al.  Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[11]  E. Sapey,et al.  Simvastatin Improves Neutrophil Function and Clinical Outcomes in Pneumonia. A Pilot Randomized Controlled Clinical Trial , 2019, American journal of respiratory and critical care medicine.

[12]  L. Leibovici,et al.  Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsis in adults - A systematic review and meta-analysis. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  E. Sapey,et al.  Pulmonary Infections in the Elderly Lead to Impaired Neutrophil Targeting, Which Is Improved by Simvastatin , 2017, American journal of respiratory and critical care medicine.

[14]  Eun-Hee Kim,et al.  The effect of fluvastatin on cardiac fibrosis and angiotensin-converting enzyme-2 expression in glucose-controlled diabetic rat hearts , 2017, Heart and Vessels.

[15]  Q. Gu,et al.  Prescription cholesterol-lowering medication use in adults aged 40 and over: United States, 2003-2012. , 2014, NCHS data brief.

[16]  K. Baumstarck,et al.  Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial. , 2013, JAMA.

[17]  D. Fedson.  Treating influenza with statins and other immunomodulatory agents. , 2013, Antiviral research.

[18]  Ping Liu,et al.  Effects of rosuvastatin on expression of angiotensin-converting enzyme 2 after vascular balloon injury in rats , 2013, Journal of geriatric cardiology : JGC.

[19]  G. Zimmer,et al.  A Vesicular Stomatitis Virus Replicon-Based Bioassay for the Rapid and Sensitive Determination of Multi-Species Type I Interferon , 2011, PloS one.

[20]  J. Lindh,et al.  What is a relevant statin concentration in cell experiments claiming pleiotropic effects? , 2011, British journal of clinical pharmacology.

[21]  V. Nizet,et al.  Statins enhance formation of phagocyte extracellular traps. , 2010, Cell host & microbe.

[22]  C. Schwegmann-Wessels,et al.  Importance of cholesterol-rich membrane microdomains in the interaction of the S protein of SARS-coronavirus with the cellular receptor angiotensin-converting enzyme 2 , 2008, Virology.

[23]  N. Seidah,et al.  Chloroquine is a potent inhibitor of SARS coronavirus infection and spread , 2005, Virology Journal.

[24]  J. Deisenhofer,et al.  Structural Mechanism for Statin Inhibition of HMG-CoA Reductase , 2001, Science.

[25]  E. Glaser.  The randomized clinical trial. , 1972, The New England journal of medicine.